To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
Clinical trial NCT04985851 · UNKNOWN
Trial details
- NCT number
- NCT04985851
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2024-06-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.